Simple Summary Human papillomavirus (HPV) is recognized as a significant risk factor for
head and neck cancers worldwide, and it is the most common cause of oropharyngeal …

Cervical cancer, the most common cancer affecting women in developing countries, is
caused by persistent infection with" high-risk" genotypes of human papillomaviruses (HPV) …

Purpose The incidence of human papilloma virus (HPV)–positive oropharyngeal cancers
has risen rapidly in recent decades among men in the United States. We investigated the US …

Objective A vaccine against common high-risk types of human papillomavirus (HPV)
associated with cervical cancer risk was recently approved. We assessed women's …

Background: Human papillomavirus (HPV) vaccine may be commercially available in a few
years. We explored the clinical benefits and cost-effectiveness of introducing an HPV16/18 …

Background Human papillomavirus (HPV)–related disease remains a significant source of
morbidity and mortality, and this underscores the need to increase HPV vaccination to …

Importance Nearly 45 000 human papillomavirus (HPV)-associated cancers are diagnosed
annually in the US. The HPV vaccine has been approved since 2006, but information on the …

This ninetieth volume of the IARC Monographs on the Evaluation of Carcinogenic Risks to
Humansconsiders human papillomaviruses (HPVs) which were evaluated by a previous …